Platelet-derived growth factor for diabetic ulcers.
D000287:Administration, Topical; D000925:Anticoagulants / Q000627:therapeutic use*; D000077214:Becaplermin; D003365:Costs and Cost Analysis; D017719:Diabetic Foot / Q000188:drug therapy*; D005782:Gels; D006801:Humans; D010982:Platelet-Derived Growth Factor / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D020574:Proto-Oncogene Proteins c-sis; D011994:Recombinant Proteins / Q000627:therapeutic use
D000925:Anticoagulants; D005782:Gels; D010982:Platelet-Derived Growth Factor; D020574:Proto-Oncogene Proteins c-sis; D011994:Recombinant Proteins; D000077214:Becaplermin